Mai Capital Management Neogenomics Inc Transaction History

Mai Capital Management

$10.1 Billion
Q3 2024

A detailed history of Mai Capital Management transactions in Neogenomics Inc stock. As of the latest transaction made, Mai Capital Management holds 15,415 shares of NEO stock, worth $252,651. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,415

Previous 15,415 -0.0%

Holding current value

$252,651

Previous $213,000 6.57%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$11.67 - $20.73 $2,917 - $5,182	-250 Reduced 1.6%	15,415 $249,000
Q1 2023 May 10, 2023	SELL	$9.09 - $19.45 $31,878 - $68,211	-3,507 Reduced 18.29%	15,665 $272,000
Q4 2022 Feb 09, 2023	BUY	$6.45 - $12.07 $12,448 - $23,295	1,930 Added 11.19%	19,172 $177,000
Q3 2022 Nov 15, 2022	SELL	$7.86 - $12.91 $5,376 - $8,830	-684 Reduced 3.82%	17,242 $148,000
Q2 2022 Jul 19, 2022	BUY	$7.06 - $13.97 $4,716 - $9,331	668 Added 3.87%	17,926 $146,000
Q1 2022 May 10, 2022	BUY	$12.15 - $35.28 $19,986 - $58,035	1,645 Added 10.54%	17,258 $210,000
Q4 2021 Feb 11, 2022	SELL	$30.49 - $48.49 $264,348 - $420,408	-8,670 Reduced 35.7%	15,613 $533,000
Q3 2021 Nov 12, 2021	BUY	$41.66 - $52.52 $583 - $735	14 Added 0.06%	24,283 $1.17 Million
Q2 2021 Jul 19, 2021	BUY	$36.62 - $51.69 $409,887 - $578,566	11,193 Added 85.6%	24,269 $1.1 Million
Q1 2021 May 10, 2021	SELL	$41.56 - $59.88 $41,560 - $59,880	-1,000 Reduced 7.1%	13,076 $631,000
Q4 2020 Feb 16, 2021	BUY	$36.08 - $56.47 $2,381 - $3,727	66 Added 0.47%	14,076 $758,000
Q3 2020 Oct 26, 2020	BUY	$33.26 - $40.48 $465,972 - $567,124	14,010 New	14,010 $517,000

Others Institutions Holding NEO

# of Institutions

295

Shares Held

125M

Call Options Held

698K

Put Options Held

120K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.06B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Mai Capital Management with notifications on news.

Account

Mai Capital Management Neogenomics Inc Transaction History